{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:52:49Z","timestamp":1794491569043,"version":"4.9.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1245\/s10434-021-10407-1","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T18:14:53Z","timestamp":1626200093000},"page":"8766-8774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy"],"prefix":"10.1245","volume":"28","author":[{"given":"Jennifer E.","family":"Tonneson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Durgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly S.","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"10407_CR1","unstructured":"Society of Surgical Oncology. 2019. https:\/\/www.choosingwisely.org\/clinician-lists\/sso-sentinel-node-biopsy-in-node-negative-women-70-and-over\/. Accessed 8 March 2021."},{"issue":"19","key":"10407_CR2","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382\u20137.","journal-title":"J Clin Oncol."},{"issue":"1","key":"10407_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","volume":"18","author":"G Martelli","year":"2011","unstructured":"Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011;18(1):125\u201333.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10407_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1245\/s10434-016-5740-z","volume":"24","author":"JC Boughey","year":"2017","unstructured":"Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP. Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Ann Surg Oncol. 2017;24(3):614\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"10407_CR5","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1245\/s10434-017-5932-1","volume":"24","author":"JL Welsh","year":"2017","unstructured":"Welsh JL, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC. Predicting nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice. Ann Surg Oncol. 2017;24(10):2881\u20138.","journal-title":"Ann Surg Oncol."},{"key":"10407_CR6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","volume":"142","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond EH, Allison KH, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018;142:1364\u201382.","journal-title":"Arch Pathol Lab Med."},{"issue":"6","key":"10407_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.amjsurg.2019.08.004","volume":"218","author":"E Calderon","year":"2019","unstructured":"Calderon E, Webb C, Kosiorek H, et al. Are we choosing wisely in elderly females with breast cancer? Am J Surg. 2019;218(6):1229\u201333.","journal-title":"Am J Surg."},{"issue":"2","key":"10407_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jgo.2016.12.003","volume":"8","author":"S Liang","year":"2017","unstructured":"Liang S, Hallet J, Simpson JS, Tricco AC, Scher AC. Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: a systemic review and meta-analysis. J Geriatric Oncol. 2017;8(2):140\u20137.","journal-title":"J Geriatric Oncol."},{"issue":"3","key":"10407_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","volume":"16","author":"IH Kunkler","year":"2015","unstructured":"Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266\u201373.","journal-title":"Lancet Oncol."},{"key":"10407_CR10","doi-asserted-by":"crossref","unstructured":"Kunkler IH. PRIME 2 Randomised Trial (Postoperative Radiotherapy in Minimum-risk Elderly): Wide Local Excision and Adjuvant Hormone Therapy +\/\u2212 Whole Breast Irradiation in Women \u2265 65 Years With Early Invasive Breast Cancer: 10-year Results. SABCS Virtual Symposium. Presented December 8\u201311, 2020.","DOI":"10.1158\/1538-7445.SABCS20-GS2-03"},{"issue":"4","key":"10407_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","volume":"74","author":"BD Smith","year":"2009","unstructured":"Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987\u20131001.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"10407_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","volume":"7","author":"C Correa","year":"2017","unstructured":"Correa C, Harris EE, Leonardi MC, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7(2):73\u20139.","journal-title":"Pract Radiat Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10407-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T15:13:41Z","timestamp":1636902821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":12,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10407"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10407-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Judy Boughey receive research support from Lilly for clinical trial. Dr. Matthew Goetz receives consulting fees to institution from Eagle Pharmaceuticals, Lilly, Biovica, Novartis, Sermonix, Context Pharm, Pfizer, Biotheranostics, and AstraZeneca and Grant funding to institution from Pfizer, Sermonix, and Lilly.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}